| Name | Title | Contact Details |
|---|
At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible. PolyNovo develops innovative medical devices utilizing the patented bioabsorbable polymer technology Novosorb®. NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways. NovoSorb BTM (Biodegradable Temporizing Matrix) is the first product commercialized by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns. We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.
Freeport Health Network/Freeport Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Freeport, IL. To find more information about Freeport Health Network/Freeport Memorial Hospital, please visit www.fhn.org
Brooklyn United Methodist Church Home is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Brooklyn, NY. To find more information about Brooklyn United Methodist Church Home, please visit www.bumch.org
Health Access Solutions is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Foster City, CA. To find more information about Health Access Solutions, please visit www.healthaccesssolutions.com
Lexicomm International, Ltd. is a Jenkintown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.